Compass Therapeutics, Inc.

CMPXNASDAQHealthcareBiotechnology

$0.86- (-)1Y −78.95%

As of Oct 16, 2026 close

Market cap: $167.50M
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $0.82$6.88
Volume (live): -
Avg. volume (3M): 5.92M

Compass Therapeutics, Inc. (CMPX) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Compass Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 11 professional research analysts

Consensus Rating

Buy

Based on 11 unique analysts

(13 total ratings in last 90 days)

High Confidence∞:1 Buy/Sell

Average Price Target

$6.13

+612.79% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest CMPX Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Sep 23, 2026	Stephen Willey	Stifel Nicolaus	Maintains	Buy	-
Sep 23, 2026	Albert Lowe	Craig-Hallum	Maintains	Buy	$15.00 → $8.00 −7.00 (−46.7%)
Sep 23, 2026	Reni Benjamin	Citizens JMP	Maintains	Buy	$10.00 → $4.00 −6.00 (−60.0%)
Sep 23, 2026	John Newman	Canaccord Genuity	Maintains	Buy	$7.00
Sep 23, 2026	Michael Schmidt	Guggenheim	Reiterates	Buy	$8.00 → $4.00 −4.00 (−50.0%)
Sep 23, 2026	Joseph Pantginis	HC Wainwright	Reiterates	Buy	$24.00 → $12.00 −12.00 (−50.0%)
Sep 22, 2026	Stephen Willey	Stifel Nicolaus	Maintains	Buy	-
Sep 22, 2026	Charles Zhu	LifeSci Capital	Upgrades	Hold	-
Sep 22, 2026	Robert Driscoll	Wedbush	Downgrades	Hold	$5.00 → $1.00 −4.00 (−80.0%)
Sep 22, 2026	Michael Schmidt	Guggenheim	Initiates Coverage	Buy	$8.00 → $4.00 −4.00 (−50.0%)
Sep 22, 2026	Matt Phipps	William Blair	Maintains	Buy	-
Aug 7, 2026	Biren Amin	Piper Sandler	Maintains	Buy	$4.00 → $6.00 +2.00 (+50.0%)
Aug 7, 2026	Andrew Berens	Leerink Partners	Maintains	Buy	$4.00 → $7.00 +3.00 (+75.0%)

Stephen Willey

Stifel Nicolaus

BuyMaintains

Sep 23

Albert Lowe

Craig-Hallum

BuyMaintains

$15.00 → $8.00

Sep 23

Reni Benjamin

Citizens JMP

BuyMaintains

$10.00 → $4.00

Sep 23

John Newman

Canaccord Genuity

BuyMaintains

$7.00

Sep 23

Michael Schmidt

Guggenheim

BuyReiterates

$8.00 → $4.00

Sep 23

Joseph Pantginis

HC Wainwright

BuyReiterates

$24.00 → $12.00

Sep 23

Stephen Willey

Stifel Nicolaus

BuyMaintains

Sep 22

Charles Zhu

LifeSci Capital

HoldUpgrades

Sep 22

Robert Driscoll

Wedbush

HoldDowngrades

$5.00 → $1.00

Sep 22

Michael Schmidt

Guggenheim

BuyInitiates Coverage

$8.00 → $4.00

Sep 22

Matt Phipps

William Blair

BuyMaintains

Sep 22

Biren Amin

Piper Sandler

BuyMaintains

$4.00 → $6.00

Aug 7

Andrew Berens

Leerink Partners

BuyMaintains

$4.00 → $7.00

Aug 7

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Sep 23, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for CMPX?

The analyst consensus rating for CMPX is Buy, based on the latest ratings from 11 analysts over the last 90 days.

What is the average price target for CMPX?

The average 12-month price target for CMPX is $6.13, representing an upside of 612.8% from the Oct 16, 2026 close of $0.86.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.